Doxa AB (SE:DOXA)
:DOXA
Want to see SE:DOXA full AI Analyst Report?
DOXA Stock Chart & Stats
kr0.44
-kr0.01(-2.66%)
At close: 4:00 PM EST
kr0.44
-kr0.01(-2.66%)
Day’s Range― - ―
52-Week Rangekr0.35 - kr0.58
Previous CloseN/A
Volume288.05K
Average Volume (3M)738.50K
Market Cap
kr491.07M
Enterprise Valuekr1.85B
Total Cash (Recent Filing)kr57.50M
Total Debt (Recent Filing)kr1.41B
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Jul 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding1,285,530,600
10 Day Avg. Volume416,677
30 Day Avg. Volume738,495
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.29
Price to Sales (P/S)8.91
P/FCF Ratio2.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained TTM revenue growth of +27.7% signals expanding product adoption and market traction in the medical instruments market. A durable top-line expansion provides capacity to scale operations, invest in R&D and distribution, and eventually absorb fixed costs as the business matures.
Improved Cash GenerationA material improvement to operating cash flow and positive free cash flow improves near-term liquidity and funds operations without immediate external financing. If sustained, this enhances survivability and strategic optionality to fund growth, capex, or deleveraging over the coming months.
Moderate Current LeverageDebt-to-equity near 0.69 indicates leverage that supports growth financing but is not currently extreme. This provides capacity to invest while retaining manageable obligations, assuming cash generation stays positive, offering a structural cushion versus highly levered peers.
Bears Say
Severe Loss-Making ProfileLarge trailing losses and deeply negative margins show the company is not yet converting revenue into profits. Persistent negative profitability erodes equity, risks cash drain, and requires sustained margin improvement or funding to reach durable financial health over the next several quarters.
Volatile ProfitabilityEarnings volatility across years undermines predictability of operating performance and planning. Such swings increase risk around cash runway, capital allocation and investor confidence, meaning management must prove consistent operational improvements to stabilise fundamentals.
Rising Leverage SwingA sharp rise in leverage in recent years signals increased balance-sheet risk. Higher debt amplifies fixed obligations and reduces flexibility to navigate losses or fund growth, potentially forcing dilutive financing or austerity if cash generation weakens.
DOXA FAQ
What was Doxa AB’s price range in the past 12 months?
Doxa AB lowest stock price was kr0.35 and its highest was kr0.58 in the past 12 months.
What is Doxa AB’s market cap?
Doxa AB’s market cap is kr491.07M.
When is Doxa AB’s upcoming earnings report date?
Doxa AB’s upcoming earnings report date is Jul 14, 2026 which is in 21 days.
How were Doxa AB’s earnings last quarter?
Doxa AB released its earnings results on Apr 21, 2026. The company reported -kr0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.016.
Is Doxa AB overvalued?
According to Wall Street analysts Doxa AB’s price is currently Overvalued.
Does Doxa AB pay dividends?
Doxa AB does not currently pay dividends.
What is Doxa AB’s EPS estimate?
Doxa AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Doxa AB have?
Doxa AB has 1,285,530,600 shares outstanding.
What happened to Doxa AB’s price movement after its last earnings report?
Doxa AB reported an EPS of -kr0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.529%.
Which hedge fund is a major shareholder of Doxa AB?
Currently, no hedge funds are holding shares in SE:DOXA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Doxa AB
Doxa AB (publ) functions as a worldwide dental enterprise, focusing on the innovation, production, and distribution of bioceramic dental solutions, which are prominently marketed under its Ceramir brand. Its product line features Crown & Bridge, a specialized dental adhesive engineered for the durable securing of prosthetic crowns and bridges. The company, headquartered in Uppsala, Sweden, began its operations in 1987.